Northwestern Mutual Wealth Management’s Ultragenyx Pharmaceutical RARE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.67K | Buy |
156
+103
| +194% | +$3.75K | ﹤0.01% | 2973 |
|
|
2025
Q1 | $1.92K | Buy |
+53
| New | +$1.92K | ﹤0.01% | 3164 |
|
|
2024
Q4 | – | Sell |
-22
| Closed | -$1.22K | – | 3834 |
|
|
2024
Q3 | $1.22K | Buy |
+22
| New | +$1.22K | ﹤0.01% | 3207 |
|
|
2024
Q1 | – | Sell |
-10
| Closed | -$478 | – | 3773 |
|
|
2023
Q4 | $478 | Sell |
10
-90
| -90% | -$4.3K | ﹤0.01% | 3281 |
|
|
2023
Q3 | $3.57K | Buy |
+100
| New | +$3.57K | ﹤0.01% | 2831 |
|
|
2023
Q2 | – | Sell |
-5
| Closed | -$201 | – | 3557 |
|
|
2023
Q1 | $201 | Buy |
+5
| New | +$201 | ﹤0.01% | 3185 |
|
|
2022
Q3 | – | Sell |
-60
| Closed | -$4K | – | 3341 |
|
|
2022
Q2 | $4K | Buy |
+60
| New | +$4K | ﹤0.01% | 2789 |
|
|
2022
Q1 | – | Sell |
-50
| Closed | -$4K | – | 3342 |
|
|
2021
Q4 | $4K | Buy |
+50
| New | +$4K | ﹤0.01% | 2851 |
|